Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play - Fierce Biotech

Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play  Fierce BiotechEli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion  The New York TimesLilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs  CNBCEli Lilly Bets $7.8 Billion That Sleep Will Be the Next Obesity  Bloomberg.comEli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion  WSJ